Table 1 Patient and tumour characteristics
From: Analysis of factors influencing molecular testing at diagnostic of colorectal cancer
All patients (n = 1269) | Patients without molecular testa (n = 789) | Patients with at least one molecular testa (n = 480) | |
|---|---|---|---|
Age (years, SD) | 71.9 ± 11.8 | 74.4 ± 11.3 | 67.8 ± 11.4 |
Sex | |||
Women | 578 (45.5%) | 356 (45.1%) | 222 (46.3%) |
Men | 691 (54.5%) | 433 (54.9%) | 258 (53.8%) |
Site of the primary tumour | |||
Rectum | 309 (24.4%) | 220 (28.0%) | 89 (18.8%) |
Right colon | 437 (34.4%) | 268 (34.0%) | 169 (35.0%) |
Left colon | 523 (41.2%) | 301 (38.0%) | 222 (46.3%) |
TNM stage | |||
Stage I | 219 (17.3%) | 194 (24.6%) | 25 (5.2%) |
Stage II | 380 (29.9%) | 265 (33.6%) | 115 (24.0%) |
Stage III | 380 (29.9%) | 232 (29.4%) | 148 (30.8%) |
Stage IV | 290 (22.8%) | 98 (12.4%) | 192 (40.0%) |
Tumour grade (MD = 173) | |||
Well | 436 (39.8%) | 250 (37.7%) | 186 (43.3%) |
Moderate | 576 (52.5%) | 369 (55.4%) | 207 (47.9%) |
Poor | 84 (7.7%) | 46 (6.9%) | 38 (8.8%) |
Geographical area of primary treatment (MD = 4) | |||
Charente-Maritime | 392 (31.0%) | 286 (36.4%) | 106 (22.1%) |
Charente | 226 (17.9%) | 171 (21.6%) | 55 (11.5%) |
Deux-Sèvres | 227 (17.9%) | 110 (14.1%) | 117 (24.4%) |
Vienne | 301 (23.8%) | 137 (17.4%) | 164 (34.2%) |
Outside the region | 119 (9.4%) | 82 (10.4%) | 37 (7.7%) |
Status of the center (MD = 4) | |||
Public Hospital | 551 (43.5%) | 381 (48.6%) | 170 (35.5%) |
Private hospital | 512 (40.5%) | 292 (37.2%) | 220 (45.7%) |
University hospital | 202 (16.0%) | 112 (14.3%) | 90 (18.8%) |